Gene · 8607
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-scale perturbation signatures from primary human CD4+ T cells improve genetics-based prioritization of immune drug targets. | bioRxiv | 2026 | 42779863 | PubTator, text mining | PubMed |
| Interrogation of functional variants in COPD GWAS loci by massively parallel reporter assays. | Am J Respir Cell Mol Biol | 2026 | 42745457 | PubTator, text mining | PubMed |
| Cellular subpopulation remodeling and biphasic molecular dynamics in glioma recurrence: a multi-omics analysis and diagnostic markers screening using liquid biopsy samples. | Transl Oncol | 2026 | 42691509 | PubTator, text mining | PubMed |
| Disruption of RBPJ in liver cancer-infiltrating T cells enhances antitumor immunity through remodeling epigenetic landscape. | Cell Death Differ | 2026 | 42562885 | PubTator, text mining | PubMed |
| RUVBL1 supports TIP60-associated proteasome adaptation and temozolomide resistance in glioblastoma. | Cell Signal | 2026 | 42551615 | PubTator, text mining | PubMed |
| Effects of Kiperin Elixea, a multicomponent antioxidant supplement, on redox homeostasis and longevity-associated gene expression in human epithelial cell models. | Front Aging | 2026 | 42375387 | PubTator, text mining | PubMed |
| (+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolism. | Acta Pharm Sin B | 2026 | 42368564 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes related to centrosome amplification in multiple myeloma. | PeerJ | 2026 | 42261309 | PubTator, text mining | PubMed |
| Insights into the function and structure of the R2TP (RUVBL1-RUVBL2-RPAP3-PIH1D1) chaperone complex. | Cell Stress Chaperones | 2026 | 42248294 | PubTator, text mining | PubMed |
| PIWIL1 activates the R2TP-TELO2-mTORC1 axis independently of piRNA to promote TOP mRNA translation in gastric cancer. | Oncogene | 2026 | 42020726 | PubTator, text mining | PubMed |
| Rapid Optimization Enabled by Single-Molecule Tracking: Discovery of a Potent RUVBL1/2 Inhibitor to Evaluate the Targeting of MYC-Driven Cancers. | J Med Chem | 2026 | 42017951 | PubTator, text mining | PubMed |
| RUVBL1 Influences Immune Infiltration and Prognosis of Patients with Colon Adenocarcinoma. | Curr Cancer Drug Targets | 2026 | 42002980 | PubTator, text mining | PubMed |
| Targeting RuvBL1 disrupts mitochondrial metabolism and structure in hepatocellular carcinoma. | JHEP Rep | 2026 | 42002035 | PubTator, text mining | PubMed |
| RUVBL1 and CRAF promote periodontal ligament stem cell osteogenic differentiation via the MEK/ERK signaling cascade. | Mol Med Rep | 2026 | 41992983 | PubTator, text mining | PubMed |
| RPAP3: Structural evolution, chaperone networks, and disease implications of a transcriptional Co-chaperone. | J Biol Chem | 2026 | 41966271 | PubTator, text mining | PubMed |
| RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells. | iScience | 2026 | 41940329 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate promotes CD8 T cell exhaustion in breast cancer via exosomal transfer of TGFBR2. | Cell Death Dis | 2026 | 41872131 | PubTator, text mining | PubMed |
| Integrative transcriptomic and machine learning analysis identifies core immune genes and pathways driving graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. | Leuk Res | 2026 | 41855695 | PubTator, text mining | PubMed |
| Methylated PIH1D1 as a Circulating Biomarker for Anthracycline-Related Cardiac Remodeling: Promise and Pragmatics. | JACC Basic Transl Sci | 2026 | 41846067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/papers